nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—psoriatic arthritis—metabolic syndrome X	0.675	1	CtDrD
Methotrexate—ALB—metabolic syndrome X	0.124	1	CbGaD
Methotrexate—Abdominal distress—Metformin—metabolic syndrome X	0.00741	0.159	CcSEcCtD
Methotrexate—Anaemia megaloblastic—Metformin—metabolic syndrome X	0.00425	0.0911	CcSEcCtD
Methotrexate—Taste metallic—Metformin—metabolic syndrome X	0.00315	0.0675	CcSEcCtD
Methotrexate—Reaction gastrointestinal—Metformin—metabolic syndrome X	0.003	0.0643	CcSEcCtD
Methotrexate—MTHFR—artery—metabolic syndrome X	0.00225	0.0467	CbGeAlD
Methotrexate—Appetite absent—Metformin—metabolic syndrome X	0.00201	0.0431	CcSEcCtD
Methotrexate—Azotaemia—Metformin—metabolic syndrome X	0.00188	0.0403	CcSEcCtD
Methotrexate—FOLR1—kidney—metabolic syndrome X	0.00182	0.0378	CbGeAlD
Methotrexate—MTHFR—blood vessel—metabolic syndrome X	0.00175	0.0364	CbGeAlD
Methotrexate—Nail disorder—Metformin—metabolic syndrome X	0.00155	0.0331	CcSEcCtD
Methotrexate—SLC19A1—adipose tissue—metabolic syndrome X	0.00144	0.0299	CbGeAlD
Methotrexate—Fungal infection—Metformin—metabolic syndrome X	0.0013	0.0278	CcSEcCtD
Methotrexate—GGH—kidney—metabolic syndrome X	0.00121	0.0251	CbGeAlD
Methotrexate—ABCC11—liver—metabolic syndrome X	0.0011	0.0229	CbGeAlD
Methotrexate—GGH—adipose tissue—metabolic syndrome X	0.00109	0.0227	CbGeAlD
Methotrexate—SLCO4C1—kidney—metabolic syndrome X	0.00107	0.0223	CbGeAlD
Methotrexate—ATIC—cardiovascular system—metabolic syndrome X	0.00105	0.0218	CbGeAlD
Methotrexate—ATIC—kidney—metabolic syndrome X	0.00103	0.0214	CbGeAlD
Methotrexate—SLC19A1—liver—metabolic syndrome X	0.00101	0.021	CbGeAlD
Methotrexate—FPGS—adipose tissue—metabolic syndrome X	0.000959	0.0199	CbGeAlD
Methotrexate—ATIC—adipose tissue—metabolic syndrome X	0.000928	0.0193	CbGeAlD
Methotrexate—SLCO1C1—kidney—metabolic syndrome X	0.000856	0.0178	CbGeAlD
Methotrexate—SLC22A11—kidney—metabolic syndrome X	0.000831	0.0173	CbGeAlD
Methotrexate—SLC22A7—kidney—metabolic syndrome X	0.000811	0.0168	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—metabolic syndrome X	0.000782	0.0162	CbGeAlD
Methotrexate—SLC46A1—liver—metabolic syndrome X	0.000778	0.0161	CbGeAlD
Methotrexate—SLCO1C1—adipose tissue—metabolic syndrome X	0.000771	0.016	CbGeAlD
Methotrexate—GGH—liver—metabolic syndrome X	0.000765	0.0159	CbGeAlD
Methotrexate—SLCO3A1—kidney—metabolic syndrome X	0.000753	0.0156	CbGeAlD
Methotrexate—Lethargy—Metformin—metabolic syndrome X	0.000742	0.0159	CcSEcCtD
Methotrexate—DHFR—cardiovascular system—metabolic syndrome X	0.000706	0.0147	CbGeAlD
Methotrexate—DHFR—kidney—metabolic syndrome X	0.000691	0.0143	CbGeAlD
Methotrexate—MTHFR—adipose tissue—metabolic syndrome X	0.000689	0.0143	CbGeAlD
Methotrexate—PGD—cardiovascular system—metabolic syndrome X	0.000679	0.0141	CbGeAlD
Methotrexate—SLCO4C1—liver—metabolic syndrome X	0.000679	0.0141	CbGeAlD
Methotrexate—SLCO3A1—adipose tissue—metabolic syndrome X	0.000678	0.0141	CbGeAlD
Methotrexate—FPGS—liver—metabolic syndrome X	0.000673	0.014	CbGeAlD
Methotrexate—Liver function test abnormal—Metformin—metabolic syndrome X	0.000672	0.0144	CcSEcCtD
Methotrexate—PGD—kidney—metabolic syndrome X	0.000664	0.0138	CbGeAlD
Methotrexate—SLCO1B3—liver—metabolic syndrome X	0.000659	0.0137	CbGeAlD
Methotrexate—Breast disorder—Metformin—metabolic syndrome X	0.000657	0.0141	CcSEcCtD
Methotrexate—ATIC—liver—metabolic syndrome X	0.000651	0.0135	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—metabolic syndrome X	0.000634	0.0132	CbGeAlD
Methotrexate—TYMS—adipose tissue—metabolic syndrome X	0.000629	0.0131	CbGeAlD
Methotrexate—DHFR—adipose tissue—metabolic syndrome X	0.000623	0.0129	CbGeAlD
Methotrexate—SLC16A1—kidney—metabolic syndrome X	0.00062	0.0129	CbGeAlD
Methotrexate—Pancreatitis—Metformin—metabolic syndrome X	0.000617	0.0132	CcSEcCtD
Methotrexate—SLCO1B1—kidney—metabolic syndrome X	0.000603	0.0125	CbGeAlD
Methotrexate—Abdominal discomfort—Metformin—metabolic syndrome X	0.000603	0.0129	CcSEcCtD
Methotrexate—PGD—adipose tissue—metabolic syndrome X	0.000599	0.0124	CbGeAlD
Methotrexate—Neutropenia—Metformin—metabolic syndrome X	0.000588	0.0126	CcSEcCtD
Methotrexate—AOX1—kidney—metabolic syndrome X	0.000585	0.0122	CbGeAlD
Methotrexate—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000584	0.0125	CcSEcCtD
Methotrexate—ABCC3—kidney—metabolic syndrome X	0.000573	0.0119	CbGeAlD
Methotrexate—ABCC10—kidney—metabolic syndrome X	0.00057	0.0118	CbGeAlD
Methotrexate—Infestation NOS—Metformin—metabolic syndrome X	0.000561	0.012	CcSEcCtD
Methotrexate—Drowsiness—Metformin—metabolic syndrome X	0.000561	0.012	CcSEcCtD
Methotrexate—Infestation—Metformin—metabolic syndrome X	0.000561	0.012	CcSEcCtD
Methotrexate—SLC16A1—adipose tissue—metabolic syndrome X	0.000559	0.0116	CbGeAlD
Methotrexate—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00053	0.0114	CcSEcCtD
Methotrexate—AOX1—adipose tissue—metabolic syndrome X	0.000528	0.011	CbGeAlD
Methotrexate—SLC22A11—liver—metabolic syndrome X	0.000525	0.0109	CbGeAlD
Methotrexate—ABCC3—adipose tissue—metabolic syndrome X	0.000516	0.0107	CbGeAlD
Methotrexate—ABCC10—adipose tissue—metabolic syndrome X	0.000513	0.0107	CbGeAlD
Methotrexate—SLC22A7—liver—metabolic syndrome X	0.000513	0.0106	CbGeAlD
Methotrexate—Hepatitis—Metformin—metabolic syndrome X	0.000503	0.0108	CcSEcCtD
Methotrexate—SLCO1A2—kidney—metabolic syndrome X	0.000491	0.0102	CbGeAlD
Methotrexate—MTHFR—liver—metabolic syndrome X	0.000484	0.01	CbGeAlD
Methotrexate—SLCO3A1—liver—metabolic syndrome X	0.000476	0.00988	CbGeAlD
Methotrexate—ABCC4—kidney—metabolic syndrome X	0.000473	0.00981	CbGeAlD
Methotrexate—Eye disorder—Metformin—metabolic syndrome X	0.00047	0.0101	CcSEcCtD
Methotrexate—SLC22A8—kidney—metabolic syndrome X	0.000469	0.00973	CbGeAlD
Methotrexate—Cardiac disorder—Metformin—metabolic syndrome X	0.000467	0.01	CcSEcCtD
Methotrexate—ABCC2—kidney—metabolic syndrome X	0.000457	0.0095	CbGeAlD
Methotrexate—Angiopathy—Metformin—metabolic syndrome X	0.000457	0.00978	CcSEcCtD
Methotrexate—Immune system disorder—Metformin—metabolic syndrome X	0.000455	0.00974	CcSEcCtD
Methotrexate—Mediastinal disorder—Metformin—metabolic syndrome X	0.000454	0.00971	CcSEcCtD
Methotrexate—Chills—Metformin—metabolic syndrome X	0.000452	0.00967	CcSEcCtD
Methotrexate—TYMS—liver—metabolic syndrome X	0.000441	0.00916	CbGeAlD
Methotrexate—Malnutrition—Metformin—metabolic syndrome X	0.000438	0.00938	CcSEcCtD
Methotrexate—Erythema—Metformin—metabolic syndrome X	0.000438	0.00938	CcSEcCtD
Methotrexate—DHFR—liver—metabolic syndrome X	0.000437	0.00907	CbGeAlD
Methotrexate—Dysgeusia—Metformin—metabolic syndrome X	0.000429	0.00919	CcSEcCtD
Methotrexate—ABCC4—adipose tissue—metabolic syndrome X	0.000426	0.00884	CbGeAlD
Methotrexate—PGD—liver—metabolic syndrome X	0.00042	0.00872	CbGeAlD
Methotrexate—Vision blurred—Metformin—metabolic syndrome X	0.000413	0.00884	CcSEcCtD
Methotrexate—Ill-defined disorder—Metformin—metabolic syndrome X	0.000407	0.00871	CcSEcCtD
Methotrexate—Malaise—Metformin—metabolic syndrome X	0.000395	0.00846	CcSEcCtD
Methotrexate—SLC16A1—liver—metabolic syndrome X	0.000392	0.00814	CbGeAlD
Methotrexate—SLCO1B1—liver—metabolic syndrome X	0.000381	0.00792	CbGeAlD
Methotrexate—ABCB1—blood vessel—metabolic syndrome X	0.000377	0.00783	CbGeAlD
Methotrexate—Myalgia—Metformin—metabolic syndrome X	0.000373	0.00799	CcSEcCtD
Methotrexate—Chest pain—Metformin—metabolic syndrome X	0.000373	0.00799	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00037	0.00793	CcSEcCtD
Methotrexate—AOX1—liver—metabolic syndrome X	0.00037	0.00768	CbGeAlD
Methotrexate—Discomfort—Metformin—metabolic syndrome X	0.000369	0.00789	CcSEcCtD
Methotrexate—ABCC1—adipose tissue—metabolic syndrome X	0.000363	0.00754	CbGeAlD
Methotrexate—ABCC3—liver—metabolic syndrome X	0.000362	0.00751	CbGeAlD
Methotrexate—ABCC10—liver—metabolic syndrome X	0.00036	0.00748	CbGeAlD
Methotrexate—Infection—Metformin—metabolic syndrome X	0.000355	0.00761	CcSEcCtD
Methotrexate—Nervous system disorder—Metformin—metabolic syndrome X	0.000351	0.00751	CcSEcCtD
Methotrexate—Thrombocytopenia—Metformin—metabolic syndrome X	0.00035	0.0075	CcSEcCtD
Methotrexate—Skin disorder—Metformin—metabolic syndrome X	0.000347	0.00744	CcSEcCtD
Methotrexate—Hyperhidrosis—Metformin—metabolic syndrome X	0.000346	0.0074	CcSEcCtD
Methotrexate—Anorexia—Metformin—metabolic syndrome X	0.000341	0.0073	CcSEcCtD
Methotrexate—Hypotension—Metformin—metabolic syndrome X	0.000334	0.00716	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000326	0.00698	CcSEcCtD
Methotrexate—Paraesthesia—Metformin—metabolic syndrome X	0.000321	0.00688	CcSEcCtD
Methotrexate—Dyspnoea—Metformin—metabolic syndrome X	0.000319	0.00683	CcSEcCtD
Methotrexate—Somnolence—Metformin—metabolic syndrome X	0.000318	0.00681	CcSEcCtD
Methotrexate—Dyspepsia—Metformin—metabolic syndrome X	0.000315	0.00674	CcSEcCtD
Methotrexate—Decreased appetite—Metformin—metabolic syndrome X	0.000311	0.00666	CcSEcCtD
Methotrexate—SLCO1A2—liver—metabolic syndrome X	0.00031	0.00644	CbGeAlD
Methotrexate—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000309	0.00661	CcSEcCtD
Methotrexate—ALB—liver—metabolic syndrome X	0.000309	0.00641	CbGeAlD
Methotrexate—Fatigue—Metformin—metabolic syndrome X	0.000308	0.0066	CcSEcCtD
Methotrexate—ABCG2—adipose tissue—metabolic syndrome X	0.000301	0.00624	CbGeAlD
Methotrexate—ABCC4—liver—metabolic syndrome X	0.000299	0.0062	CbGeAlD
Methotrexate—Feeling abnormal—Metformin—metabolic syndrome X	0.000295	0.00631	CcSEcCtD
Methotrexate—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000292	0.00626	CcSEcCtD
Methotrexate—ABCC2—liver—metabolic syndrome X	0.000289	0.006	CbGeAlD
Methotrexate—Urticaria—Metformin—metabolic syndrome X	0.000284	0.00608	CcSEcCtD
Methotrexate—Abdominal pain—Metformin—metabolic syndrome X	0.000283	0.00605	CcSEcCtD
Methotrexate—Asthenia—Metformin—metabolic syndrome X	0.000257	0.00549	CcSEcCtD
Methotrexate—ABCC1—liver—metabolic syndrome X	0.000255	0.00529	CbGeAlD
Methotrexate—Pruritus—Metformin—metabolic syndrome X	0.000253	0.00542	CcSEcCtD
Methotrexate—Diarrhoea—Metformin—metabolic syndrome X	0.000245	0.00524	CcSEcCtD
Methotrexate—Dizziness—Metformin—metabolic syndrome X	0.000236	0.00506	CcSEcCtD
Methotrexate—Vomiting—Metformin—metabolic syndrome X	0.000227	0.00487	CcSEcCtD
Methotrexate—Rash—Metformin—metabolic syndrome X	0.000225	0.00483	CcSEcCtD
Methotrexate—Dermatitis—Metformin—metabolic syndrome X	0.000225	0.00482	CcSEcCtD
Methotrexate—Headache—Metformin—metabolic syndrome X	0.000224	0.0048	CcSEcCtD
Methotrexate—Nausea—Metformin—metabolic syndrome X	0.000212	0.00455	CcSEcCtD
Methotrexate—ABCG2—liver—metabolic syndrome X	0.000211	0.00438	CbGeAlD
Methotrexate—ABCB1—cardiovascular system—metabolic syndrome X	0.000168	0.00349	CbGeAlD
Methotrexate—ABCB1—kidney—metabolic syndrome X	0.000165	0.00342	CbGeAlD
Methotrexate—ABCB1—adipose tissue—metabolic syndrome X	0.000148	0.00308	CbGeAlD
Methotrexate—ABCB1—liver—metabolic syndrome X	0.000104	0.00216	CbGeAlD
Methotrexate—TYMS—Metabolism—APOA1—metabolic syndrome X	8.87e-06	8.38e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	8.86e-06	8.37e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—LPL—metabolic syndrome X	8.86e-06	8.37e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—metabolic syndrome X	8.85e-06	8.36e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCA1—metabolic syndrome X	8.84e-06	8.36e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC2A4—metabolic syndrome X	8.84e-06	8.36e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CD36—metabolic syndrome X	8.83e-06	8.34e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—INS—metabolic syndrome X	8.78e-06	8.3e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT2—metabolic syndrome X	8.73e-06	8.25e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HMGCR—metabolic syndrome X	8.73e-06	8.25e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOB—metabolic syndrome X	8.68e-06	8.2e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARA—metabolic syndrome X	8.67e-06	8.19e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—metabolic syndrome X	8.66e-06	8.19e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	8.62e-06	8.14e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GGT1—metabolic syndrome X	8.56e-06	8.09e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GOT1—metabolic syndrome X	8.56e-06	8.09e-05	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	8.56e-06	8.09e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—metabolic syndrome X	8.54e-06	8.07e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—metabolic syndrome X	8.53e-06	8.06e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.5e-06	8.04e-05	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—AKT1—metabolic syndrome X	8.47e-06	8.01e-05	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—AKT1—metabolic syndrome X	8.47e-06	8.01e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—metabolic syndrome X	8.46e-06	8e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	8.46e-06	7.99e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—FABP4—metabolic syndrome X	8.45e-06	7.98e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—APOB—metabolic syndrome X	8.42e-06	7.96e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CD36—metabolic syndrome X	8.41e-06	7.95e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—metabolic syndrome X	8.41e-06	7.95e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC2A4—metabolic syndrome X	8.4e-06	7.94e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCA1—metabolic syndrome X	8.4e-06	7.94e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AGT—metabolic syndrome X	8.4e-06	7.93e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—LPL—metabolic syndrome X	8.29e-06	7.83e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOE—metabolic syndrome X	8.23e-06	7.77e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARG—metabolic syndrome X	8.15e-06	7.7e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—G6PD—metabolic syndrome X	8.15e-06	7.7e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GOT1—metabolic syndrome X	8.14e-06	7.69e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GGT1—metabolic syndrome X	8.14e-06	7.69e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOA1—metabolic syndrome X	8.13e-06	7.69e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOB—metabolic syndrome X	8.08e-06	7.63e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—metabolic syndrome X	8.05e-06	7.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	8.04e-06	7.6e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	8.01e-06	7.57e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—INS—metabolic syndrome X	8e-06	7.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HDAC3—metabolic syndrome X	7.95e-06	7.51e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—AKT1—metabolic syndrome X	7.95e-06	7.51e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—metabolic syndrome X	7.92e-06	7.49e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—AKT1—metabolic syndrome X	7.88e-06	7.45e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PLA2G4A—metabolic syndrome X	7.86e-06	7.42e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARA—metabolic syndrome X	7.82e-06	7.39e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—metabolic syndrome X	7.81e-06	7.38e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARG—metabolic syndrome X	7.81e-06	7.38e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCA1—metabolic syndrome X	7.78e-06	7.35e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC2A4—metabolic syndrome X	7.78e-06	7.35e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCKR—metabolic syndrome X	7.77e-06	7.34e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPA—metabolic syndrome X	7.77e-06	7.34e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—metabolic syndrome X	7.74e-06	7.31e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—LPL—metabolic syndrome X	7.71e-06	7.29e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—APOA1—metabolic syndrome X	7.7e-06	7.28e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—metabolic syndrome X	7.7e-06	7.28e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—INS—metabolic syndrome X	7.66e-06	7.24e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AGT—metabolic syndrome X	7.58e-06	7.16e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GGT1—metabolic syndrome X	7.54e-06	7.12e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT1—metabolic syndrome X	7.54e-06	7.12e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PLA2G6—metabolic syndrome X	7.53e-06	7.11e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	7.49e-06	7.07e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	7.47e-06	7.06e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOA5—metabolic syndrome X	7.45e-06	7.04e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOE—metabolic syndrome X	7.42e-06	7.01e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	7.38e-06	6.98e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	7.37e-06	6.97e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOA1—metabolic syndrome X	7.34e-06	6.93e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—metabolic syndrome X	7.33e-06	6.93e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CD36—metabolic syndrome X	7.33e-06	6.92e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOB—metabolic syndrome X	7.27e-06	6.87e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	7.24e-06	6.84e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—AKT1—metabolic syndrome X	7.21e-06	6.81e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARG—metabolic syndrome X	7.17e-06	6.77e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—G6PD—metabolic syndrome X	7.14e-06	6.75e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	7.11e-06	6.71e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	7.09e-06	6.7e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PLA2G4A—metabolic syndrome X	7.07e-06	6.68e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—metabolic syndrome X	7.04e-06	6.65e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—INS—metabolic syndrome X	7.03e-06	6.64e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—metabolic syndrome X	7.02e-06	6.64e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—metabolic syndrome X	7.01e-06	6.63e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	7.01e-06	6.62e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HDAC3—metabolic syndrome X	6.97e-06	6.58e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOE—metabolic syndrome X	6.95e-06	6.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—LPL—metabolic syndrome X	6.94e-06	6.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TRIB3—metabolic syndrome X	6.93e-06	6.55e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOB—metabolic syndrome X	6.91e-06	6.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	6.88e-06	6.5e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOA1—metabolic syndrome X	6.87e-06	6.49e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—metabolic syndrome X	6.84e-06	6.47e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARA—metabolic syndrome X	6.81e-06	6.44e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCKR—metabolic syndrome X	6.81e-06	6.43e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPA—metabolic syndrome X	6.81e-06	6.43e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—metabolic syndrome X	6.72e-06	6.35e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PLA2G4A—metabolic syndrome X	6.72e-06	6.35e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—metabolic syndrome X	6.68e-06	6.31e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	6.67e-06	6.3e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—AKT1—metabolic syndrome X	6.6e-06	6.24e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AGT—metabolic syndrome X	6.6e-06	6.23e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	6.59e-06	6.23e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—LPL—metabolic syndrome X	6.59e-06	6.23e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CD36—metabolic syndrome X	6.59e-06	6.23e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOA5—metabolic syndrome X	6.53e-06	6.17e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—metabolic syndrome X	6.47e-06	6.11e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOE—metabolic syndrome X	6.46e-06	6.11e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—metabolic syndrome X	6.44e-06	6.09e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF1—metabolic syndrome X	6.44e-06	6.08e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—metabolic syndrome X	6.41e-06	6.06e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOB—metabolic syndrome X	6.39e-06	6.04e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOA1—metabolic syndrome X	6.39e-06	6.04e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—INS—metabolic syndrome X	6.34e-06	5.99e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CD36—metabolic syndrome X	6.27e-06	5.92e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	6.23e-06	5.88e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PLA2G4A—metabolic syndrome X	6.22e-06	5.88e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NAMPT—metabolic syndrome X	6.21e-06	5.87e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IRS1—metabolic syndrome X	6.2e-06	5.85e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.18e-06	5.84e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LIPC—metabolic syndrome X	6.17e-06	5.83e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCK—metabolic syndrome X	6.17e-06	5.83e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—metabolic syndrome X	6.16e-06	5.82e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—metabolic syndrome X	6.14e-06	5.81e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOC3—metabolic syndrome X	6.14e-06	5.8e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARA—metabolic syndrome X	6.13e-06	5.79e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINE1—metabolic syndrome X	6.11e-06	5.78e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—LPL—metabolic syndrome X	6.11e-06	5.77e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—metabolic syndrome X	6.08e-06	5.74e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TRIB3—metabolic syndrome X	6.07e-06	5.74e-05	CbGpPWpGaD
Methotrexate—PGD—Metabolism—AKT1—metabolic syndrome X	6.04e-06	5.71e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CETP—metabolic syndrome X	5.96e-06	5.63e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AGT—metabolic syndrome X	5.94e-06	5.61e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—INS—metabolic syndrome X	5.93e-06	5.61e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—AKT1—metabolic syndrome X	5.93e-06	5.6e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	5.84e-06	5.52e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—metabolic syndrome X	5.84e-06	5.51e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARA—metabolic syndrome X	5.82e-06	5.5e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOE—metabolic syndrome X	5.82e-06	5.5e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—metabolic syndrome X	5.81e-06	5.49e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CD36—metabolic syndrome X	5.8e-06	5.48e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOA1—metabolic syndrome X	5.75e-06	5.43e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SCARB1—metabolic syndrome X	5.7e-06	5.39e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AGT—metabolic syndrome X	5.64e-06	5.33e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—metabolic syndrome X	5.64e-06	5.33e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—metabolic syndrome X	5.63e-06	5.32e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—metabolic syndrome X	5.56e-06	5.26e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SREBF1—metabolic syndrome X	5.54e-06	5.23e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOE—metabolic syndrome X	5.53e-06	5.22e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—INS—metabolic syndrome X	5.52e-06	5.22e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOA1—metabolic syndrome X	5.46e-06	5.16e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SERPINE1—metabolic syndrome X	5.45e-06	5.15e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NAMPT—metabolic syndrome X	5.44e-06	5.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LIPC—metabolic syndrome X	5.41e-06	5.11e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCK—metabolic syndrome X	5.41e-06	5.11e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARA—metabolic syndrome X	5.39e-06	5.1e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMGCR—metabolic syndrome X	5.39e-06	5.09e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT2—metabolic syndrome X	5.39e-06	5.09e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOC3—metabolic syndrome X	5.38e-06	5.08e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AGT—metabolic syndrome X	5.22e-06	4.94e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CETP—metabolic syndrome X	5.22e-06	4.93e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	5.2e-06	4.92e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—metabolic syndrome X	5.2e-06	4.92e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—metabolic syndrome X	5.16e-06	4.87e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	5.12e-06	4.84e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOE—metabolic syndrome X	5.12e-06	4.84e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—metabolic syndrome X	5.09e-06	4.81e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—metabolic syndrome X	5.07e-06	4.79e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—metabolic syndrome X	5.06e-06	4.78e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOA1—metabolic syndrome X	5.06e-06	4.78e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—metabolic syndrome X	5.04e-06	4.76e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SCARB1—metabolic syndrome X	5e-06	4.72e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—INS—metabolic syndrome X	4.97e-06	4.7e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.86e-06	4.59e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SREBF1—metabolic syndrome X	4.85e-06	4.59e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—metabolic syndrome X	4.84e-06	4.58e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—metabolic syndrome X	4.81e-06	4.55e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC2A4—metabolic syndrome X	4.8e-06	4.54e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCA1—metabolic syndrome X	4.8e-06	4.54e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—metabolic syndrome X	4.76e-06	4.5e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—AKT1—metabolic syndrome X	4.76e-06	4.49e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—INS—metabolic syndrome X	4.72e-06	4.46e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT2—metabolic syndrome X	4.72e-06	4.46e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMGCR—metabolic syndrome X	4.72e-06	4.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT1—metabolic syndrome X	4.65e-06	4.39e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGT1—metabolic syndrome X	4.65e-06	4.39e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—AKT1—metabolic syndrome X	4.65e-06	4.39e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	4.63e-06	4.37e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—metabolic syndrome X	4.58e-06	4.33e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—metabolic syndrome X	4.56e-06	4.3e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—metabolic syndrome X	4.46e-06	4.21e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—metabolic syndrome X	4.43e-06	4.19e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INS—metabolic syndrome X	4.37e-06	4.13e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—metabolic syndrome X	4.36e-06	4.12e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—metabolic syndrome X	4.33e-06	4.09e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—AKT1—metabolic syndrome X	4.23e-06	3.99e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	4.21e-06	3.98e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCA1—metabolic syndrome X	4.21e-06	3.98e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—metabolic syndrome X	4.14e-06	3.91e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT1—metabolic syndrome X	4.07e-06	3.85e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGT1—metabolic syndrome X	4.07e-06	3.85e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—metabolic syndrome X	4.01e-06	3.79e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—metabolic syndrome X	3.99e-06	3.77e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—AKT1—metabolic syndrome X	3.98e-06	3.76e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOB—metabolic syndrome X	3.95e-06	3.73e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—AKT1—metabolic syndrome X	3.89e-06	3.68e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—metabolic syndrome X	3.86e-06	3.65e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PLA2G4A—metabolic syndrome X	3.84e-06	3.63e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—metabolic syndrome X	3.83e-06	3.62e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—metabolic syndrome X	3.79e-06	3.58e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPL—metabolic syndrome X	3.77e-06	3.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CD36—metabolic syndrome X	3.58e-06	3.38e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—AKT1—metabolic syndrome X	3.54e-06	3.34e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—metabolic syndrome X	3.51e-06	3.31e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOB—metabolic syndrome X	3.46e-06	3.27e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—metabolic syndrome X	3.44e-06	3.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	3.36e-06	3.18e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARA—metabolic syndrome X	3.33e-06	3.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPL—metabolic syndrome X	3.3e-06	3.12e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—AKT1—metabolic syndrome X	3.22e-06	3.05e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AGT—metabolic syndrome X	3.22e-06	3.05e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOE—metabolic syndrome X	3.16e-06	2.98e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CD36—metabolic syndrome X	3.14e-06	2.96e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOA1—metabolic syndrome X	3.12e-06	2.95e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—AKT1—metabolic syndrome X	3.09e-06	2.92e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARA—metabolic syndrome X	2.92e-06	2.76e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AKT1—metabolic syndrome X	2.83e-06	2.68e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AGT—metabolic syndrome X	2.82e-06	2.67e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOE—metabolic syndrome X	2.77e-06	2.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—metabolic syndrome X	2.75e-06	2.6e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOA1—metabolic syndrome X	2.74e-06	2.58e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INS—metabolic syndrome X	2.7e-06	2.55e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—AKT1—metabolic syndrome X	2.68e-06	2.53e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—metabolic syndrome X	2.59e-06	2.45e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AKT1—metabolic syndrome X	2.56e-06	2.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—metabolic syndrome X	2.41e-06	2.28e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—AKT1—metabolic syndrome X	2.39e-06	2.26e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—metabolic syndrome X	2.37e-06	2.24e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INS—metabolic syndrome X	2.36e-06	2.23e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AKT1—metabolic syndrome X	2.23e-06	2.1e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—metabolic syndrome X	2.17e-06	2.05e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—metabolic syndrome X	2.16e-06	2.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—metabolic syndrome X	2.07e-06	1.96e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AKT1—metabolic syndrome X	2e-06	1.89e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AKT1—metabolic syndrome X	1.9e-06	1.8e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.9e-06	1.79e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AKT1—metabolic syndrome X	1.76e-06	1.67e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AKT1—metabolic syndrome X	1.09e-06	1.03e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AKT1—metabolic syndrome X	9.53e-07	9.01e-06	CbGpPWpGaD
